View of DEVELOPMENT AND VALIDATION OF AN LC-MS-MS METHOD FOR CABOZANTINIB IN HUMAN PLASMA USING NAPROXEN AS AN INTERNAL STANDARD USING QUALITY BY DESIGN (QBD)

Return to Article Details DEVELOPMENT AND VALIDATION OF AN LC-MS-MS METHOD FOR CABOZANTINIB IN HUMAN PLASMA USING NAPROXEN AS AN INTERNAL STANDARD USING QUALITY BY DESIGN (QBD) Download Download PDF